{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:59:07Z","timestamp":1793642347244,"version":"4.5.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-02400-5","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:14:35Z","timestamp":1748564075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Tailored treatment of specific diagnosis improves symptoms and quality of life in patients with myocardial Ischemia and Non-obstructive Coronary Arteries"],"prefix":"10.1038","volume":"15","author":[{"given":"Piotr","family":"Szolc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Guzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Niewiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Kleczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bernacik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Diachyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"St\u0105p\u00f3r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"\u017bmudka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Legutko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"issue":"37","key":"2400_CR1","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1093\/eurheartj\/ehaa503","volume":"41","author":"V Kunadian","year":"2020","unstructured":"Kunadian, V. et al. An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J 41(37), 3504\u20133520 (2020).","journal-title":"Eur Heart J"},{"issue":"12","key":"2400_CR2","doi-asserted-by":"publisher","first-page":"e008126","DOI":"10.1161\/CIRCINTERVENTIONS.119.008126","volume":"12","author":"TJ Ford","year":"2019","unstructured":"Ford, T. J. et al. Ischemia and no obstructive coronary artery disease: Prevalence and correlates of coronary vasomotion disorders. Circ. Cardiovasc. Interv. 12(12), e008126. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.119.008126 (2019).","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"6","key":"2400_CR3","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","volume":"33","author":"L Jespersen","year":"2012","unstructured":"Jespersen, L. et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur. Heart J. 33(6), 734\u2013744. https:\/\/doi.org\/10.1093\/eurheartj\/ehr331 (2012).","journal-title":"Eur. Heart J."},{"key":"2400_CR4","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","volume":"72","author":"VR Taqueti","year":"2018","unstructured":"Taqueti, V. R. & Di Carli, M. F. Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review. J. Am. Coll. Cardiol. 72, 2625\u20132641 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"33","key":"2400_CR5","first-page":"2565","volume":"38","author":"JF Beltrame","year":"2017","unstructured":"Beltrame, J. F. et al. International standardization of diagnostic criteria for vasospastic angina. Eur. Heart J. 38(33), 2565\u20132568 (2017).","journal-title":"Eur. Heart J."},{"key":"2400_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijcard.2017.08.068","volume":"250","author":"P Ong","year":"2018","unstructured":"Ong, P. et al. International standardization of diagnostic criteria for microvascular angina. Int. J. Cardiol. 250, 16\u201320 (2018).","journal-title":"Int. J. Cardiol."},{"key":"2400_CR7","first-page":"16814","volume":"134","author":"P Szolc","year":"2024","unstructured":"Szolc, P. et al. Heterogeneous and overlapping mechanisms of ischemia and non-obstructive coronary arteries: In-hospital results of the MOSAIC-COR registry. Polish. Arch. Intern. Med. 134, 16814 (2024).","journal-title":"Polish. Arch. Intern. Med."},{"key":"2400_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s12265-024-10575-x","volume":"18","author":"A G\u0105secka","year":"2024","unstructured":"G\u0105secka, A. et al. Endothelial cell-derived extracellular vesicles allow to differentiate between various endotypes of INOCA: A multicentre, prospective, cohort study. J. Cardiovasc. Transl. Res. 18, 305 (2024).","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"17","key":"2400_CR9","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1001\/jama.2014.14681","volume":"312","author":"TM Maddox","year":"2014","unstructured":"Maddox, T. M. et al. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA 312(17), 1754\u20131763 (2014).","journal-title":"JAMA"},{"issue":"9","key":"2400_CR10","doi-asserted-by":"publisher","first-page":"25171","DOI":"10.1161\/JAHA.121.025171","volume":"11","author":"SH Lee","year":"2022","unstructured":"Lee, S. H. et al. Clinical relevance of ischemia with nonobstructive coronary arteries according to coronary microvascular dysfunction. J. Am. Heart Assoc. 11(9), 25171 (2022).","journal-title":"J. Am. Heart Assoc."},{"issue":"11","key":"2400_CR11","doi-asserted-by":"publisher","first-page":"e004336","DOI":"10.1161\/JAHA.116.004336","volume":"5","author":"SW Cho","year":"2016","unstructured":"Cho, S. W. et al. Clinical outcomes of vasospastic angina patients presenting with acute coronary syndrome. J. Am. Heart Assoc. 5(11), e004336 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"2400_CR12","doi-asserted-by":"publisher","first-page":"175394472412304","DOI":"10.1177\/17539447241230400","volume":"18","author":"K Jenkins","year":"2024","unstructured":"Jenkins, K. et al. Vasospastic angina: A review on diagnostic approach and management Plain language summary. Ther. Adv. Cardiovasc. Dis. 18, 17539447241230400 (2024).","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"issue":"23","key":"2400_CR13","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","volume":"72","author":"TJ Ford","year":"2018","unstructured":"Ford, T. J. et al. Stratified medical therapy using invasive coronary function testing in angina: The CorMicA trial. J. Am. Coll. Cardiol. 72(23), 2841\u20132855 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"24","key":"2400_CR14","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1161\/01.CIR.103.24.2928","volume":"103","author":"GJW Bech","year":"2001","unstructured":"Bech, G. J. W. et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis. Circulation 103(24), 2928\u20132934. https:\/\/doi.org\/10.1161\/01.CIR.103.24.2928 (2001).","journal-title":"Circulation"},{"key":"2400_CR15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1161\/CIRCULATIONAHA.118.037021","volume":"139","author":"JM Lee","year":"2019","unstructured":"Lee, J. M. et al. Physiological and clinical assessment of resting physiological indexes: Resting full-cycle ratio, diastolic pressure ratio, and instantaneous wave-free ratio. Circulation 139, 889\u2013900. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.037021 (2019).","journal-title":"Circulation"},{"issue":"9","key":"2400_CR16","doi-asserted-by":"publisher","first-page":"1003067","DOI":"10.3389\/fcvm.2022.1003067","volume":"5","author":"J Legutko","year":"2022","unstructured":"Legutko, J. et al. The impact of coronary microvascular dysfunction on the discordance between fractional flow reserve and resting full-cycle ratio in patients with chronic coronary syndromes. Front. Cardiovasc. Med. 5(9), 1003067 (2022).","journal-title":"Front. Cardiovasc. Med."},{"issue":"6","key":"2400_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.5603\/KP.a2019.0060","volume":"77","author":"J Legutko","year":"2019","unstructured":"Legutko, J., Kleczy\u0144ski, P., Dziewierz, A., Rzeszutko, \u0141 & Dudek, D. Adenosine intracoronary bolus dose escalation versus intravenous infusion to induce maximum coronary hyperemia for fractional flow reserve assessment. Kardiol. Pol. 77(6), 610\u2013617 (2019).","journal-title":"Kardiol. Pol."},{"issue":"12","key":"2400_CR18","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.36740\/WLek202012108","volume":"73","author":"P Szolc","year":"2020","unstructured":"Szolc, P., Niewiara, L., Kawulak, M. & Szkodon, K. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as predictors of coronary microcirculatory disease occurrence and outcome in patients with chronic coronary syndrome and no significant coronary artery stenosis. Wiad. Lek. 73(12), 2598\u20132606 (2020).","journal-title":"Wiad. Lek."},{"key":"2400_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.005361","author":"WF Fearon","year":"2017","unstructured":"Fearon, W. F. & Kobayashi, Y. 126 invasive assessment of the coronary microvasculature: The index of microcirculatory resistance. Circ. Cardiovasc. Interv. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.117.005361 (2017).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"2400_CR20","first-page":"54295","volume":"114","author":"P Ong","year":"2016","unstructured":"Ong, P., Athanasiadis, A. & Sechtem, U. 2016 Intracoronary acetylcholine provocation testing for assessment of coronary vasomotor disorders. J. Vis. Exp. 114, 54295 (2016).","journal-title":"J. Vis. Exp."},{"issue":"10","key":"2400_CR21","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1371\/journal.pmed.0040297","volume":"4","author":"JP Vandenbroucke","year":"2007","unstructured":"Vandenbroucke, J. P. et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. PLoS Med. 4(10), 1628\u20131654 (2007).","journal-title":"PLoS Med."},{"issue":"9596","key":"2400_CR22","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm, E. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 370(9596), 1453\u20131457 (2007).","journal-title":"Lancet"},{"issue":"1","key":"2400_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang, R. M. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 28(1), 1\u201339 (2015).","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"6","key":"2400_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware, J. E. & Sherbourne, C. D. The MOS 36-item short-form health survey (Sf-36): I. Conceptual framework and item selection. Med. Care 30(6), 473\u2013483 (1992).","journal-title":"Med. Care"},{"issue":"7","key":"2400_CR25","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jcmg.2021.01.041","volume":"14","author":"CL Schumann","year":"2021","unstructured":"Schumann, C. L. et al. Functional and economic impact of INOCA and influence of coronary microvascular dysfunction. JACC Cardiovasc. Imaging 14(7), 1369\u20131379 (2021).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"2400_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijcard.2022.09.047","volume":"371","author":"M Gulati","year":"2023","unstructured":"Gulati, M. et al. Ischemia with no obstructive coronary artery disease (INOCA): A patient self-report quality of life survey from INOCA international. Int. J. Cardiol. 371, 28\u201339 (2023).","journal-title":"Int. J. Cardiol."},{"key":"2400_CR27","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s11883-023-01144-9","volume":"25","author":"T Takahashi","year":"2023","unstructured":"Takahashi, T., Gupta, A., Samuels, B. A. & Wei, J. Invasive coronary assessment in myocardial ischemia with no obstructive coronary arteries. Curr. Atheroscler. Rep. 25, 729\u2013740. https:\/\/doi.org\/10.1007\/s11883-023-01144-9 (2023).","journal-title":"Curr. Atheroscler. Rep."},{"issue":"10","key":"2400_CR28","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.cjca.2022.07.005","volume":"38","author":"M Parvand","year":"2022","unstructured":"Parvand, M. et al. One-year prospective follow-up of women with INOCA and MINOCA at a Canadian Women\u2019s Heart Centre. Can. J. Cardiol. 38(10), 1600\u20131610 (2022).","journal-title":"Can. J. Cardiol."},{"issue":"1","key":"2400_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jcin.2019.11.001","volume":"13","author":"TJ Ford","year":"2020","unstructured":"Ford, T. J. et al. 1-year outcomes of angina management guided by invasive coronary function testing (CorMicA). JACC Cardiovasc. Interv. 13(1), 33 (2020).","journal-title":"JACC Cardiovasc. Interv."},{"issue":"4","key":"2400_CR30","doi-asserted-by":"publisher","first-page":"318","DOI":"10.5114\/aic.2023.1338","volume":"19","author":"\u0141 Niewiara","year":"2023","unstructured":"Niewiara, \u0141 et al. The change of angina levels in patients with chronic coronary syndromes and coronary microcirculatory dysfunction\u2014a prospective study with 24 months follow-up. Adv. Interv. Cardiol. w Kardiol. Interw. 19(4), 318\u2013325. https:\/\/doi.org\/10.5114\/aic.2023.1338 (2023).","journal-title":"Adv. Interv. Cardiol. w Kardiol. Interw."},{"key":"2400_CR31","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.3390\/jcm12175646","volume":"12","author":"S Ranasinghe","year":"2023","unstructured":"Ranasinghe, S. et al. Sex differences in quality of life in patients with ischemia with no obstructive coronary artery disease (INOCA): A patient self-report retrospective survey from INOCA international. J. Clin. Med. 12, 5646 (2023).","journal-title":"J. Clin. Med."},{"issue":"5","key":"2400_CR32","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00380-022-02213-w","volume":"38","author":"K Xiao","year":"2023","unstructured":"Xiao, K. et al. Association of vascular endothelial function and quality of life in patients with ischemia and non-obstructive coronary artery disease. Heart Vessels 38(5), 617\u2013625 (2023).","journal-title":"Heart Vessels"},{"issue":"8","key":"2400_CR33","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jacc.2011.02.074","volume":"58","author":"JK Min","year":"2011","unstructured":"Min, J. K. et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease. J. Am. Coll. Cardiol. 58(8), 849\u2013860 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"2400_CR34","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jacc.2015.12.053","volume":"67","author":"JM Lee","year":"2016","unstructured":"Lee, J. M. et al. Coronary flow reserve and microcirculatory resistance in patients with intermediate coronary stenosis. J. Am. Coll. Cardiol. 67(10), 1158\u20131169 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"2400_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.acvd.2018.08.002","volume":"112","author":"F Picard","year":"2019","unstructured":"Picard, F., Sayah, N., Spagnoli, V., Adjedj, J. & Varenne, O. Vasospastic angina: A literature review of current evidence. Arch. Cardiovasc. Dis. 112(1), 44\u201355 (2019).","journal-title":"Arch. Cardiovasc. Dis."},{"issue":"2","key":"2400_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jacc.2016.04.050","volume":"68","author":"JM Ahn","year":"2016","unstructured":"Ahn, J. M. et al. Prognosis of variant angina manifesting as aborted sudden cardiac death. J. Am. Coll. 68(2), 137\u2013145 (2016).","journal-title":"J. Am. Coll."},{"issue":"1","key":"2400_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijcard.2006.06.016","volume":"118","author":"GA Lanza","year":"2007","unstructured":"Lanza, G. A. et al. Current clinical features, diagnostic assessment and prognostic determinants of patients with variant angina. Int. J. Cardiol. 118(1), 41\u201347 (2007).","journal-title":"Int. J. Cardiol."},{"issue":"19","key":"2400_CR38","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2019.08.1056","volume":"74","author":"A Suda","year":"2019","unstructured":"Suda, A. et al. Coronary functional abnormalities in patients with angina and nonobstructive coronary artery disease. J. Am. Coll. Cardiol. 74(19), 2350\u20132360 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2400_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ahj.2021.03.011","volume":"237","author":"EM Handberg","year":"2021","unstructured":"Handberg, E. M. et al. Rationale and design of the Women\u2019s Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial. Am. Heart J. 237, 90\u2013103 (2021).","journal-title":"Am. Heart J."},{"issue":"229","key":"2400_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ahj.2020.07.007","volume":"1","author":"AJ Morrow","year":"2020","unstructured":"Morrow, A. J. et al. Rationale and design of the Medical Research Council\u2019s Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial. Am. Heart J. 1(229), 70\u201380 (2020).","journal-title":"Am. Heart J."},{"issue":"1","key":"2400_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/ehjcvp\/pvu020","volume":"1","author":"P Ong","year":"2015","unstructured":"Ong, P., Athanasiadis, A. & Sechtem, U. Pharmacotherapy for coronary microvascular dysfunction. Eur. Hear J. Cardiovasc. Pharmacother. 1(1), 65\u201371. https:\/\/doi.org\/10.1093\/ehjcvp\/pvu020 (2015).","journal-title":"Eur. Hear J. Cardiovasc. Pharmacother."},{"key":"2400_CR42","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","volume":"72","author":"VR Taqueti","year":"2018","unstructured":"Taqueti, V. R. & Di Carli, M. F. Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review. J. Am. Coll. Cardiol. 72, 2625\u20132641 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2400_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjco.2020.09.005","author":"T Kofler","year":"2021","unstructured":"Kofler, T. et al. Efficacy of ranolazine for treatment of coronary microvascular dysfunctiond\u2014a systematic review and meta-analysis of randomized trials. CJC Open https:\/\/doi.org\/10.1016\/j.cjco.2020.09.005 (2021).","journal-title":"CJC Open"},{"issue":"2","key":"2400_CR44","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.21037\/qims-23-1029","volume":"14","author":"H Ling","year":"2024","unstructured":"Ling, H. et al. Ranolazine for improving coronary microvascular function in patients with nonobstructive coronary artery disease: A systematic review and meta-analysis with a trial sequential analysis of randomized controlled trials. Quant. Imaging Med. Surg. 14(2), 1451\u20131465. https:\/\/doi.org\/10.21037\/qims-23-1029 (2024).","journal-title":"Quant. Imaging Med. Surg."},{"key":"2400_CR45","doi-asserted-by":"publisher","first-page":"100302","DOI":"10.1016\/j.ahjo.2023.100302","volume":"30","author":"ND Ashokprabhu","year":"2023","unstructured":"Ashokprabhu, N. D., Quesada, O., Alvarez, Y. R. & Henry, T. D. INOCA\/ANOCA: Mechanisms and novel treatments. Am. Heart J. Plus Cardiol. Res. Pract. 30, 100302 (2023).","journal-title":"Am. Heart J. Plus Cardiol. Res. Pract."},{"key":"2400_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad655.1296","author":"E Gnan","year":"2023","unstructured":"Gnan, E. et al. Treatment of microvascular angina with the coronary sinus reducer: a first experience. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehad655.1296 (2023).","journal-title":"Eur Heart J."},{"issue":"12","key":"2400_CR47","first-page":"1291","volume":"82","author":"P Szolc","year":"2024","unstructured":"Szolc, P. et al. Drug refractory arrhythmic vasospastic angina successfully treated with bilateral cardiac sympathetic denervation. Pol. Hear J. 82(12), 1291\u20131292 (2024).","journal-title":"Pol. Hear J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02400-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02400-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02400-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:14:36Z","timestamp":1748564076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02400-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2400"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02400-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5798707\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18968"}}